Evidence map›Paper›PMID 30220832›Full record

ArticleMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents2018

Evaluation of the effect of 2-(2,4-dihydroxyphenyl)-4

Arkadiusz Czerwonka, Marta K Lemieszek, Monika Karpińska, Joanna Matysiak, Andrzej Niewiadomy, Wojciech Rzeski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Benzofuran compound fromFrontiers in pharmacology · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Arkadiusz Czerwonka1Department of Virology and Immunology, Maria Curie-Skłodowska University, Akademicka 19, Lublin, 20-400 Poland.ORCID 0000-0002-2299-4881
Marta K Lemieszek2Department of Medical Biology, Institute of Rural Health, Jaczewskiego 2, Lublin, 20-090 Poland.
Monika Karpińska3Institute of Industrial Organic Chemistry, Annopol 6, Warsaw, 03-236 Poland.
Joanna Matysiak4Department of Chemistry, University of Life Sciences, Akademicka 15, Lublin, 20-950 Poland.
Andrzej Niewiadomy3Institute of Industrial Organic Chemistry, Annopol 6, Warsaw, 03-236 Poland.
Wojciech Rzeski1Department of Virology and Immunology, Maria Curie-Skłodowska University, Akademicka 19, Lublin, 20-400 Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this paper, we present the biological effect of the newly synthesized 2-(2,4-dihydroxyphenyl)-4

Indexed as

1,3-thiazine derivatives2-(2,4-dihydroxyphenyl)-4H-benzofuro[3,2-d][1,3]thiazin-4-oneAnti-proliferative actionCell cycle arrestColorectal cancer

Identifiers

PMID30220832
PMCPMC6133158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.